| First Author | Pott J | Year | 2011 |
| Journal | Proc Natl Acad Sci U S A | Volume | 108 |
| Issue | 19 | Pages | 7944-9 |
| PubMed ID | 21518880 | Mgi Jnum | J:172800 |
| Mgi Id | MGI:5009066 | Doi | 10.1073/pnas.1100552108 |
| Citation | Pott J, et al. (2011) IFN-{lambda} determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108(19):7944-9 |
| abstractText | Type I and type III IFNs bind to different cell-surface receptors but induce identical signal transduction pathways, leading to the expression of antiviral host effector molecules. Despite the fact that type III IFN (IFN-lambda) has been shown to predominantly act on mucosal organs, in vivo infection studies have failed to attribute a specific, nonredundant function. Instead, a predominant role of type I IFN was observed, which was explained by the ubiquitous expression of the type I IFN receptor. Here we comparatively analyzed the role of functional IFN-lambda and type I IFN receptor signaling in the innate immune response to intestinal rotavirus infection in vivo, and determined viral replication and antiviral gene expression on the cellular level. We observed that both suckling and adult mice lacking functional receptors for IFN-lambda were impaired in the control of oral rotavirus infection, whereas animals lacking functional receptors for type I IFN were similar to wild-type mice. Using Mx1 protein accumulation as marker for IFN responsiveness of individual cells, we demonstrate that intestinal epithelial cells, which are the prime target cells of rotavirus, strongly responded to IFN-lambda but only marginally to type I IFN in vivo. Systemic treatment of suckling mice with IFN-lambda repressed rotavirus replication in the gut, whereas treatment with type I IFN was not effective. These results are unique in identifying a critical role of IFN-lambda in the epithelial antiviral host defense. |
